METTL3/14 expression and the m6A level has been reported to be reduced in the neurons or brains of Alzheimer’s Disease (AD) patients52,53, 5×FAD mouse model54, and 6-OHDA induced rat model of Parkinson's Disease55. Here, METTL3 is linked to early-onset autosomal dominant Alzheimer disease.